Antibiotics in chicken production are a concern primarily because they breed antibiotic-resistant bacteria, which can spread to humans and make common infections harder to treat. The global livestock industry uses over 110,000 tons of antibiotics per year, and without intervention, that figure is projected to climb to roughly 143,000 tons by 2040. Much of that use happens in poultry, where antibiotics have historically been given not just to treat sick birds but to make them grow faster on less feed.
How Resistant Bacteria Develop
When chickens receive antibiotics regularly, especially at low doses over long periods, the bacteria living in their gut face constant pressure to survive. The ones that develop or acquire resistance genes thrive, while susceptible bacteria die off. Over time, the birds become reservoirs for bacteria that no longer respond to the drugs designed to kill them.
This isn’t a theoretical problem. A study of poultry in East Africa found that nearly 86% of Campylobacter isolates from chickens were resistant to at least one antibiotic, and about 41% were multidrug-resistant, meaning they could survive exposure to three or more different drug classes. Some isolates resisted five of the six antibiotics tested. Campylobacter is one of the most common causes of food poisoning worldwide, so when it stops responding to treatment, the consequences are real: longer illness, more hospitalizations, and in severe cases, limited options for doctors.
How Resistant Bacteria Reach People
Resistant bacteria travel from poultry to humans through several routes. The most direct is handling or eating undercooked chicken. Bacteria like Salmonella and Campylobacter can survive on raw meat and kitchen surfaces, and if they carry resistance genes, those genes come along for the ride.
But the food supply chain is only part of the picture. Poultry waste is a major vector. Untreated chicken manure often ends up on agricultural fields or in waterways, contaminating soil and surface water with fecal bacteria. Workers in live poultry markets face especially high exposure. Observational research in Bangladesh found that market workers had roughly ten times more direct contact events with poultry and poultry waste than farm workers or people raising backyard flocks. These workers handled, slaughtered, and processed birds with bare hands, rinsing afterward in containers of water without soap.
Resistant bacteria can also pass their resistance genes to entirely different species of bacteria through a process called horizontal gene transfer. This means a harmless gut bacterium in a chicken can hand off its resistance gene to a dangerous pathogen in a human, even if the original chicken bacterium never caused disease itself. It’s one reason why antibiotic use in animals can fuel resistance in bacteria that have nothing to do with poultry.
Growth Promotion vs. Disease Treatment
For decades, the poultry industry used antibiotics at sub-therapeutic doses mixed into feed or water. The purpose wasn’t to treat infection. It was to promote faster growth and improve feed efficiency, squeezing more meat out of less grain. This constant, low-level exposure is the perfect recipe for breeding resistance, because it applies just enough antibiotic pressure to select for resistant bacteria without wiping out the population entirely.
In 2013, the FDA issued guidance recommending that drug manufacturers voluntarily remove growth promotion from the approved uses of medically important antibiotics in food animals. The policy also required that remaining therapeutic uses be placed under veterinary oversight rather than sold over the counter. By 2017, these changes were largely implemented in the United States. Antibiotics classified as medically important to human medicine can no longer be legally used in U.S. poultry production solely to make birds grow faster.
That was a significant step, but it has limits. Antibiotics can still be used to treat and prevent disease in flocks, and critics argue that “prevention” can sometimes look a lot like the old growth-promotion model, with entire flocks receiving drugs before any bird shows symptoms. Globally, many countries have no equivalent restrictions, and total livestock antibiotic use is expected to increase by nearly 19% by 2030.
What About Residues in the Meat You Buy?
A separate concern from resistance is whether actual antibiotic residue ends up in the chicken on your plate. The FDA sets maximum tolerance levels for veterinary drug residues in meat, and the USDA’s Food Safety and Inspection Service tests thousands of samples each year. In fiscal year 2018, FSIS analyzed 7,908 scheduled samples across all meat types and found just 26 chemical residue violations. The violation rate for routine sampling is extremely low.
That said, the testing program also examines suspect animals flagged by inspectors. Of the 3,845 suspect samples submitted to labs that year, 644 contained at least one residue violation. These are animals that were already identified as potentially problematic, so the higher rate isn’t representative of the broader supply, but it does show that violations happen.
For most consumers buying chicken at a grocery store in the U.S., antibiotic residues in the meat itself are not the primary risk. The bigger concern, by far, is the resistant bacteria the production system creates and spreads.
What “No Antibiotics Ever” Labels Mean
If you’ve seen labels like “Raised Without Antibiotics” or “No Antibiotics Ever” on chicken packaging, those claims are regulated by the USDA. Producers must provide documentation supporting the claim, and as of 2024, updated USDA guidelines recommend that companies using these labels implement routine sampling and testing programs to verify that no antibiotics were administered, or obtain third-party certification that includes testing.
These labels do mean the birds received no antibiotics at any point in their lives. If a bird in a “No Antibiotics Ever” flock gets sick and needs treatment, it must be removed from that program. The label doesn’t guarantee the meat is free of resistant bacteria, since birds can pick up resistant organisms from their environment, but it does mean the production of those birds didn’t contribute to the resistance problem through direct antibiotic use.
Alternatives the Industry Is Exploring
With antibiotics being phased out of growth promotion, the poultry industry needs other ways to keep birds healthy in the dense conditions of commercial farming. Two of the most promising alternatives are competitive exclusion and bacteriophage therapy.
Competitive exclusion works by introducing beneficial bacteria into a chick’s gut early in life, essentially filling the ecological niches before harmful bacteria can establish themselves. There is an approved product on the market, but its commercial use has been limited by high production costs and narrow methods of administration.
Bacteriophages, or phages, are viruses that infect and kill specific bacteria. Unlike antibiotics, which wipe out broad swaths of bacteria (good and bad), phages are highly targeted. A phage designed to kill Salmonella won’t touch Campylobacter or the bird’s beneficial gut flora. Research has shown phages can reduce contamination on poultry carcasses and kill pathogens in the intestinal tracts of live birds and even in eggs. They also replicate on their own: when a phage kills its target bacterium, it releases more phages, amplifying the effect.
Neither alternative has yet reached the scale or cost-effectiveness needed to fully replace antibiotics across the global poultry industry. Vaccines, improved hygiene practices, and better farm management (like reducing flock density and improving ventilation) also play important roles in reducing the need for antibiotics in the first place.